跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial
Approved
STANDARD
NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial
Southern XP IP Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4b78b9d541b9f3c6
Company
Southern XP IP Pty Ltd
Type
Standard
Approval Details
Approval Id
4b78b9d541b9f3c6
Product Name
NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial
Artg Id
381452
Artg Name
NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial
Sponsor
Southern XP IP Pty Ltd
Company Detail Path
/organization/southern-xp-ip-pty-ltd
Artg Date
2022-11-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4b78b9d541b9f3c6
Type
Standard
Back to TGA Approvals
